FindTrial
Sign In

Long-term Efficacy and Safety of Bronchoscopic Interventional Therapy for Tuberculosis-related Airway Stenosis: A Nationwide Multicenter Clinical Cohort Study

Long-term Efficacy and Safety of Bronchoscopic Interventional Therapy for Tuberculosis-related Airway Stenosis: A Nationwide Multicenter Clinical Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500114454
Enrollment
Unknown
Registered
2025-12-12
Start date
2025-12-20
Completion date
Unknown
Last updated
2025-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

tracheobronchial tuberculosis

Interventions

Non-surgical group:None
Stent placement group:None
Balloon dilation group:None

Sponsors

Beijing Chest Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Clinically diagnosed with tuberculosis complicated by airway stenosis; 2. Underwent non-surgical treatment, stent placement, or balloon dilation; 3. Possess complete clinical data and follow-up records.

Exclusion criteria

Exclusion criteria: 1. Presence of other serious respiratory diseases; 2. Serious complications occur during treatment, affecting the assessment of efficacy; 3. Incomplete follow-up data.

Design outcomes

Primary

MeasureTime frame
Symptom improvement rate;—

Secondary

MeasureTime frame
rate of unchanged symptoms;rate of worsened symptoms;all-cause mortality rate;rate of composite negative outcome;—

Countries

China

Contacts

Public ContactNie Wenjuan

Beijing Chest Hospital, Capital Medical University

94642975@qq.com+86 135 5215 6672

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026